All In MedTech

Device Trial Radar · NCT04769453

Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty

Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty, Randomized, Controlled Trial: iTrack (Nova Eye Medical) Compared to Omni (Sight Sciences)

Last checked: Nov 20, 2026Latest source record: Mar 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

20

Actual

Start

Apr 29, 2021

Primary completion

Jan 26, 2023

Study completion Jan 26, 2023

Sponsor

Lead sponsor
Nova Eye, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 24, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Factorial
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, multicenter, randomized, single-masked clinical trial to evaluate the effectiveness outcomes of canaloplasty performed as a standalone procedure with the iTrack microcatheter to the Omni surgical system, and to compare the effectiveness of two types of Ophthalmic Viscoelastic Device (OVD).

Conditions

  • Primary Open Angle Glaucoma

Interventions

  • Canaloplasty using the iTrack microcatheter with Healon GV ProDevice

    360 degree microcatheterization and viscodilation of Schlemm's canal

  • Canaloplasty using the Omni surgical system with Healon GV ProDevice

    360 degree microcatheterization and viscodilation of Schlemm's canal

  • Canaloplasty using the iTrack microcatheter with Healon ProDevice

    360 degree microcatheterization and viscodilation of Schlemm's canal

  • Canaloplasty using the Omni surgical system with Healon ProDevice

    360 degree microcatheterization and viscodilation of Schlemm's canal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction in mean Intraocular pressure (IOP) and glaucoma medication use at 12 months post-interventionTime frame: 12 months

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Arizona Advanced Eye Research Institute

    Glendale, Arizona

  • Beverly Hills Institute of Ophthalmology

    Beverly Hills, California

  • Coastal Vision

    Orange, California

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.